维普中文期刊产品整合服务

New combination test for hepatitis C virus genotype and viral load determination using Amplicor GT HCV MONITOR test v2.0

查看全文 作　　者：Motokazu [1]Mukaide;Yasuhito [2]Tanaka;Hirokazu [1]Kakuda;Kei [3]Fujiwara;Fuat [4]Kurbanov;Eturo [3]Orito;Kentaro [5]Yoshioka;Kiyotaka [6]Fujise;Shoji [7]Harada;Takazumi [1]Kozaki;Kazuo [7]Takemura;Kazumasa [7]Hikiji;Masashi [2]Mizokami 高影响力作者 机构地区：[1]SRL Inc.,5-6-50,Shinmachi,Hino-shi,Tokyo 191-0002,Japan;[2]Department of Clinical Molecular Informative Medicine Nagoya City University Graduate School of Medical Sciences,Kawasumi,Mizuho,Nagoya 467-8601,Japan;[3]Department of Internal Medicine and Molecular Science Nagoya City University Graduate School of Medical Sciences,Kawasumi,Mizuho,Nagoya 467-8601,Japan;[4]Department of Clinical Molecular Informative Medicine Nagoya City University Graduate School of Medical Sciences,Kawasumi,Mizuho,Nagoya 467-8601, Japan;[5]Third Department of Internal Medicine Nagoya University,School of Medicine,65 Tsuruma,Showa,Nagoya 466-8550,Japan;[6]Division of Gastroenterology and Hepatology Department of Internal Medicine (Kashiwa),The Jikei University School of Medicine,163-1,Kashiwashita,Kashiwa,Chiba 277-8567,Japan;[7]SRL Inc.,5-6-50,Shinmachi,Hmo-shi,Tokyo 191-0002,Japan高影响力机构 出　　处：《World Journal of Gastroenterology》索引2005年第11卷第4期,共7页高影响力期刊 摘　　要：AIM: To develop a new sensitive and inexpensive hepatitis C virus (HCV) combination test (HCV Guideline test) that enables the determination of HCV genotypes 1, 2 and 3,and simultaneous determination of HCV viral load using commercial Amplicor GT HCV MONITOR test v2.0 (microwell version).METHODS: The HCV Guideline test used the PCR product generated in commercial Amplicor GT HCV Monitor test v2.0 for viral load measurement using microwell plate version of Amplicor HCV Monitor and also captured on separate plates containing capture probes and competitive oligonucleotide probes specific for HCV genotypes 1, 2 and 3, The HCV genotype was subsequently determined using the biotin-labeled PCR product and five biotin-labeled HCV-specific probes.RESULTS: The sensitivity of the HCV Guideline test was 0.5 KIU/mL. Specificity of the HCV Guideline test was confirmed by direct sequencing of HCV core region and molecular evolutionary analyses based on a panel of 31 samples. The comparison of the HCV Guideline test and an in-house HCV core genotyping assay using 252 samples from chronic hepatitis C patients indicated concordant results for 97.2% of samples (59.5% genotype 1, 33.7% genotype 2, 6.0% genotype 3, and 0.8% mixed genotypes).Similarly, the HCV Guideline test showed concordance with a serological test, and the serological test failed to assign any serotype in 12.7% of the samples, indicating a better sensitivity of the HCV Guideline test.CONCLUSION: Clinically, both viral load and genotypes (1, 2 and 3) have been found to be major predictors of antiviral therapy outcome regarding chronic hepatitis C based on guidelines and they are, in normal circumstances,performed as separate stand-alone assays. The HCV Guideline test is a useful method for screening large cohorts in a routine clinical setting for determining the treatment regimen and for predicting the outcome of antiviral therapy of chronic hepatitis C. 关 键 词：新化合物试验 丙肝病毒 基因型 病毒测定 GT HCV HCC
相关文献

参考文献(34)

引证文献(3)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费